Logo image of PHM7.DE

ALTRIA GROUP INC (PHM7.DE) Stock Fundamental Analysis

FRA:PHM7 - Deutsche Boerse Ag - US02209S1033 - Common Stock - Currency: EUR

51.43  -0.38 (-0.73%)

Fundamental Rating

6

Taking everything into account, PHM7 scores 6 out of 10 in our fundamental rating. PHM7 was compared to 4 industry peers in the Tobacco industry. While PHM7 belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. PHM7 has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year PHM7 was profitable.
In the past year PHM7 had a positive cash flow from operations.
In the past 5 years PHM7 has always been profitable.
In the past 5 years PHM7 always reported a positive cash flow from operatings.
PHM7.DE Yearly Net Income VS EBIT VS OCF VS FCFPHM7.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

1.2 Ratios

The Return On Assets of PHM7 (28.48%) is better than 100.00% of its industry peers.
The Return On Invested Capital of PHM7 (36.74%) is better than 100.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for PHM7 is significantly above the industry average of 20.78%.
The last Return On Invested Capital (36.74%) for PHM7 is above the 3 year average (34.24%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 28.48%
ROE N/A
ROIC 36.74%
ROA(3y)22.85%
ROA(5y)16.84%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)34.24%
ROIC(5y)31.38%
PHM7.DE Yearly ROA, ROE, ROICPHM7.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400

1.3 Margins

PHM7 has a Profit Margin of 42.97%. This is amongst the best in the industry. PHM7 outperforms 100.00% of its industry peers.
In the last couple of years the Profit Margin of PHM7 has grown nicely.
Looking at the Operating Margin, with a value of 49.62%, PHM7 belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
PHM7's Operating Margin has improved in the last couple of years.
The Gross Margin of PHM7 (60.40%) is comparable to the rest of the industry.
PHM7's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 49.62%
PM (TTM) 42.97%
GM 60.4%
OM growth 3Y2.47%
OM growth 5Y3%
PM growth 3Y70.3%
PM growth 5YN/A
GM growth 3Y3.41%
GM growth 5Y3.35%
PHM7.DE Yearly Profit, Operating, Gross MarginsPHM7.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), PHM7 is creating value.
The number of shares outstanding for PHM7 has been reduced compared to 1 year ago.
Compared to 5 years ago, PHM7 has less shares outstanding
Compared to 1 year ago, PHM7 has a worse debt to assets ratio.
PHM7.DE Yearly Shares OutstandingPHM7.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
PHM7.DE Yearly Total Debt VS Total AssetsPHM7.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.2 Solvency

PHM7 has an Altman-Z score of 4.48. This indicates that PHM7 is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of PHM7 (4.48) is better than 100.00% of its industry peers.
PHM7 has a debt to FCF ratio of 3.08. This is a good value and a sign of high solvency as PHM7 would need 3.08 years to pay back of all of its debts.
PHM7 has a Debt to FCF ratio of 3.08. This is amongst the best in the industry. PHM7 outperforms 100.00% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.08
Altman-Z 4.48
ROIC/WACC4.6
WACC7.98%
PHM7.DE Yearly LT Debt VS Equity VS FCFPHM7.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B

2.3 Liquidity

PHM7 has a Current Ratio of 0.57. This is a bad value and indicates that PHM7 is not financially healthy enough and could expect problems in meeting its short term obligations.
PHM7's Current ratio of 0.57 is on the low side compared to the rest of the industry. PHM7 is outperformed by 75.00% of its industry peers.
PHM7 has a Quick Ratio of 0.57. This is a bad value and indicates that PHM7 is not financially healthy enough and could expect problems in meeting its short term obligations.
With a decent Quick ratio value of 0.47, PHM7 is doing good in the industry, outperforming 75.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.57
Quick Ratio 0.47
PHM7.DE Yearly Current Assets VS Current LiabilitesPHM7.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

3

3. Growth

3.1 Past

PHM7 shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.89%.
Measured over the past 5 years, PHM7 shows a small growth in Earnings Per Share. The EPS has been growing by 4.03% on average per year.
PHM7 shows a decrease in Revenue. In the last year, the revenue decreased by -2.63%.
Measured over the past years, PHM7 shows a decrease in Revenue. The Revenue has been decreasing by -0.89% on average per year.
EPS 1Y (TTM)5.89%
EPS 3Y3.63%
EPS 5Y4.03%
EPS Q2Q%6.96%
Revenue 1Y (TTM)-2.63%
Revenue growth 3Y-2.62%
Revenue growth 5Y-0.89%
Sales Q2Q%-4.2%

3.2 Future

PHM7 is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.38% yearly.
The Revenue is expected to grow by 0.73% on average over the next years.
EPS Next Y8.22%
EPS Next 2Y5.28%
EPS Next 3Y4.56%
EPS Next 5Y3.38%
Revenue Next Year-1.12%
Revenue Next 2Y-0.63%
Revenue Next 3Y-0.73%
Revenue Next 5Y0.73%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
PHM7.DE Yearly Revenue VS EstimatesPHM7.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B 20B 25B
PHM7.DE Yearly EPS VS EstimatesPHM7.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 11.25, which indicates a very decent valuation of PHM7.
Compared to the rest of the industry, the Price/Earnings ratio of PHM7 is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 26.53, PHM7 is valued rather cheaply.
PHM7 is valuated reasonably with a Price/Forward Earnings ratio of 10.32.
The rest of the industry has a similar Price/Forward Earnings ratio as PHM7.
PHM7 is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.27, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 11.25
Fwd PE 10.32
PHM7.DE Price Earnings VS Forward Price EarningsPHM7.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PHM7 indicates a somewhat cheap valuation: PHM7 is cheaper than 75.00% of the companies listed in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as PHM7.
Industry RankSector Rank
P/FCF 11.7
EV/EBITDA 10.03
PHM7.DE Per share dataPHM7.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of PHM7 may justify a higher PE ratio.
PEG (NY)1.37
PEG (5Y)2.79
EPS Next 2Y5.28%
EPS Next 3Y4.56%

6

5. Dividend

5.1 Amount

PHM7 has a Yearly Dividend Yield of 6.87%, which is a nice return.
Compared to an average industry Dividend Yield of 5.80, PHM7 pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.39, PHM7 pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.87%

5.2 History

The dividend of PHM7 has a limited annual growth rate of 4.03%.
Dividend Growth(5Y)4.03%
Div Incr Years6
Div Non Decr Years6
PHM7.DE Yearly Dividends per sharePHM7.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0 0 0 0 0

5.3 Sustainability

67.18% of the earnings are spent on dividend by PHM7. This is not a sustainable payout ratio.
The dividend of PHM7 is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP67.18%
EPS Next 2Y5.28%
EPS Next 3Y4.56%
PHM7.DE Yearly Income VS Free CF VS DividendPHM7.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B
PHM7.DE Dividend Payout.PHM7.DE Dividend Payout, showing the Payout Ratio.PHM7.DE Dividend Payout.PayoutRetained Earnings

ALTRIA GROUP INC

FRA:PHM7 (6/10/2025, 4:45:13 PM)

51.43

-0.38 (-0.73%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryTobacco
Earnings (Last)04-29 2025-04-29/bmo
Earnings (Next)07-30 2025-07-30/bmo
Inst Owners61.16%
Inst Owner ChangeN/A
Ins Owners0.07%
Ins Owner ChangeN/A
Market Cap86.63B
Analysts72.17
Price Target52 (1.11%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.87%
Yearly Dividend3.47
Dividend Growth(5Y)4.03%
DP67.18%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.08%
Min EPS beat(2)-2.78%
Max EPS beat(2)0.61%
EPS beat(4)1
Avg EPS beat(4)-2.07%
Min EPS beat(4)-5.41%
Max EPS beat(4)0.61%
EPS beat(8)1
Avg EPS beat(8)-2.46%
EPS beat(12)1
Avg EPS beat(12)-2.69%
EPS beat(16)2
Avg EPS beat(16)-2.47%
Revenue beat(2)0
Avg Revenue beat(2)-3.36%
Min Revenue beat(2)-4.94%
Max Revenue beat(2)-1.77%
Revenue beat(4)0
Avg Revenue beat(4)-3.57%
Min Revenue beat(4)-4.99%
Max Revenue beat(4)-1.77%
Revenue beat(8)0
Avg Revenue beat(8)-3.63%
Revenue beat(12)4
Avg Revenue beat(12)2.55%
Revenue beat(16)8
Avg Revenue beat(16)6.85%
PT rev (1m)3.25%
PT rev (3m)-2.76%
EPS NQ rev (1m)-0.15%
EPS NQ rev (3m)0.44%
EPS NY rev (1m)1.38%
EPS NY rev (3m)0.93%
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)-1.16%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)-0.93%
Valuation
Industry RankSector Rank
PE 11.25
Fwd PE 10.32
P/S 4.17
P/FCF 11.7
P/OCF 11.5
P/B N/A
P/tB N/A
EV/EBITDA 10.03
EPS(TTM)4.57
EY8.89%
EPS(NY)4.98
Fwd EY9.69%
FCF(TTM)4.4
FCFY8.55%
OCF(TTM)4.47
OCFY8.7%
SpS12.33
BVpS-1.83
TBVpS-11.72
PEG (NY)1.37
PEG (5Y)2.79
Profitability
Industry RankSector Rank
ROA 28.48%
ROE N/A
ROCE 46.85%
ROIC 36.74%
ROICexc 45.27%
ROICexgc 672.84%
OM 49.62%
PM (TTM) 42.97%
GM 60.4%
FCFM 35.66%
ROA(3y)22.85%
ROA(5y)16.84%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)34.24%
ROIC(5y)31.38%
ROICexc(3y)39.44%
ROICexc(5y)36.25%
ROICexgc(3y)239.58%
ROICexgc(5y)176.43%
ROCE(3y)43.65%
ROCE(5y)40%
ROICexcg growth 3Y38.27%
ROICexcg growth 5Y47.52%
ROICexc growth 3Y4.07%
ROICexc growth 5Y13.18%
OM growth 3Y2.47%
OM growth 5Y3%
PM growth 3Y70.3%
PM growth 5YN/A
GM growth 3Y3.41%
GM growth 5Y3.35%
F-Score7
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.08
Debt/EBITDA 1.94
Cap/Depr 49.66%
Cap/Sales 0.61%
Interest Coverage 250
Cash Conversion 71.32%
Profit Quality 82.98%
Current Ratio 0.57
Quick Ratio 0.47
Altman-Z 4.48
F-Score7
WACC7.98%
ROIC/WACC4.6
Cap/Depr(3y)70.81%
Cap/Depr(5y)74.31%
Cap/Sales(3y)0.74%
Cap/Sales(5y)0.75%
Profit Quality(3y)109.56%
Profit Quality(5y)169.16%
High Growth Momentum
Growth
EPS 1Y (TTM)5.89%
EPS 3Y3.63%
EPS 5Y4.03%
EPS Q2Q%6.96%
EPS Next Y8.22%
EPS Next 2Y5.28%
EPS Next 3Y4.56%
EPS Next 5Y3.38%
Revenue 1Y (TTM)-2.63%
Revenue growth 3Y-2.62%
Revenue growth 5Y-0.89%
Sales Q2Q%-4.2%
Revenue Next Year-1.12%
Revenue Next 2Y-0.63%
Revenue Next 3Y-0.73%
Revenue Next 5Y0.73%
EBIT growth 1Y-0.23%
EBIT growth 3Y-0.22%
EBIT growth 5Y2.09%
EBIT Next Year5.6%
EBIT Next 3Y3.07%
EBIT Next 5Y1.64%
FCF growth 1Y6.3%
FCF growth 3Y1.5%
FCF growth 5Y2.55%
OCF growth 1Y5.28%
OCF growth 3Y1.36%
OCF growth 5Y2.24%